Outcomes of Barrett’s oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study
Authors:
- Julien WipffJWJulien Wipff
- Romain CoriatRCRomain Coriat
- Michela MasciocchiMMMichela Masciocchi
- Paola CaramaschiPCPaola Caramaschi
- Chris T. DerkCDChris T. Derk
- Eric HachullaEHEric Hachulla
- Valeria RiccieriVRValeria Riccieri
- Luc MouthonLMLuc Mouthon
- Dorota KrasowskaDorota Krasowska
- Lidia P. AnanyevaLALidia P. Ananyeva
- André KahanAKAndré Kahan
- Marco Matucci-CerinicMMMarco Matucci-Cerinic
Open Access
- 16 March 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 50 (8) , 1440-1444
Abstract
Objective. Barrett’s oesophagus (BE) is the major risk factor for oesophageal adenocarcinoma (EAC). SSc is associated with an increased risk of BE related to chronic reflux. The aim of this study is to determine the outcomes of BE and estimate the EAC risk in SSc patients over a 3-year prospective study. Methods. SSc patients were recruited through EUSTAR network centres. Inclusion criterion was a recent histological finding of BE. The patients were then prospectively followed and, as recommended, a second oesophageal endoscopy was performed according to the presence of BE-related dysplasia at baseline. Results. A total of 50 SSc patients with BE (40 without and 10 with dysplasia) were included and 46 completed the follow-up (138 patient-years). During the 3-year follow-up, 4 of the 46 BE patients (3% per year) were diagnosed with high-grade dysplasia/EAC, of which one developed cardial EAC. EAC incidence in the BE subgroup with dysplasia increased to 4% per year compared with the absence of EAC cases in the BE subgroup without dysplasia at baseline. Conclusion. Our results, in accordance with previous published data suggesting an increased risk of EAC or cardial adenocarcinoma in SSc, highlight the need for accurate follow-up of BE SSc patients at risk of developing adenocarcinoma.Keywords
This publication has 17 references indexed in Scilit:
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the Rheumatic Diseases, 2010
- Use of Proton Pump Inhibitors and Risk of Progression of Barrett's Esophagus to Neoplastic LesionsAmerican Journal of Gastroenterology, 2009
- Routinely diagnosed low‐grade dysplasia in Barrett’s oesophagus: a population‐based study of natural historyHistopathology, 2009
- Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagusGut, 2008
- Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagusScandinavian Journal of Gastroenterology, 2008
- Gastrointestinal Manifestations of Systemic SclerosisDigestive Diseases and Sciences, 2007
- Prevalence of Barrett's esophagus in systemic sclerosisArthritis & Rheumatism, 2005
- Barrettʼs oesophagusEuropean Journal of Gastroenterology & Hepatology, 2000
- Barrett's metaplasia and adenocarcinoma of the esophagus in sclerodermaThe American Journal of Medicine, 1987
- Systemic sclerosis (scleroderma) and esophageal adenocarcinoma: Is increased patient screening necessary?Gastroenterology, 1985